Longevity Health Holdings, Inc. - Common Stock (XAGE)
0.1562
-0.0030 (-1.88%)
NASDAQ · Last Trade: Apr 18th, 9:52 PM EDT
NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
By Halper Sadeh LLC · Via GlobeNewswire · April 16, 2025
BALA CYNWYD, Pa. , April 16, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · April 16, 2025
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Longevity Health Holdings, Inc. (NasdaqCM: XAGE) and 20/20 BioLabs, Inc. Upon closing of the proposed transaction, Longevity shareholders are expected to own approximately 49.9% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger is fair to Longevity shareholders.
By Kahn Swick & Foti, LLC · Via Business Wire · April 15, 2025
Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Longevity Health Holdings, Inc. (NASDAQ: XAGE) and 20/20 BioLabs, Inc. is fair to Longevity shareholders. Upon closing of the proposed transaction, Longevity shareholders are expected to own approximately 49.9% of the combined company.
By Halper Sadeh LLC · Via Business Wire · April 14, 2025